双侧乳房切除假体乳房再造中治疗侧与预防侧结局比较
本研究回顾性分析2015至2020年本院215例假体乳房再造患者,比较治疗侧与预防侧乳房切除的并发症差异。结果显示治疗侧血清肿形成风险更高(P=0.03;OR=3.500;95%CI 1.099-14.603),而感染、缺血或血肿发生率无显著差异。
要点
- 治疗侧乳房切除的血清肿形成风险高于预防侧(OR=3.500;95%CI 1.099-14.603;P=0.03)。
- 感染、缺血或血肿发生率在治疗侧与预防侧之间无显著差异。
- 治疗侧单侧血清肿患者中14%(2/14)接受放疗,预防侧为25%(1/4)。
核心结论
- 在接受乳房切除联合假体再造的患者中,治疗侧乳房切除的血清肿形成风险增加。
研究设计与样本
- 回顾性分析2015至2020年本院假体乳房再造病例,共纳入215例患者。
- 排除最终假体置入后随访不足6个月、使用自体皮瓣再造、扩张器或假体破裂、需移除装置的转移性疾病或未完成再造前死亡的患者。
- 采用McNemar检验比较治疗侧与预防侧乳房并发症发生率的差异。
主要发现
- 治疗侧与预防侧乳房在感染、缺血或血肿发生率上无显著差异。
- 治疗侧乳房切除的血清肿形成风险更高(P=0.03;OR=3.500;95%CI 1.099-14.603)。
- 治疗侧单侧血清肿患者中14%(2/14)接受放疗,预防侧单侧血清肿患者中25%(1/4)接受放疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Increasingly patients with unilateral breast cancer elect to undergo bilateral mastectomy with subsequent reconstruction. Studies have aimed to better identify the risks associated with performing mastectomy on the noncancerous breast. Our study aims to identify differences in complications between therapeutic and prophylactic mastectomy in patients undergoing implant-based breast reconstruction. METHODS: A retrospective analysis of implant-based breast reconstruction from 2015 to 2020 at our institution was completed. Patients with less than 6-month follow-up after final implant placement had reconstruction using autologous flaps, expander or implant rupture, metastatic disease requiring device removal, or death before completion of reconstruction were excluded. McNemar test identified differences in incidence of complications for therapeutic and prophylactic breasts. RESULTS: After analysis of 215 patients, we observed no significant difference in incidence of infection, ischemia, or hematoma between the therapeutic and prophylactic sides. Therapeutic mastectomies had higher odds of seroma formation ( P = 0.03; odds ratio, 3.500; 95% confidence interval, 1.099-14.603). Radiation treatment status was analyzed for patients with seroma; 14% of patients unilateral seroma of the therapeutic side underwent radiation (2 of 14), compared with 25% patients with unilateral seroma of the prophylactic side (1 of 4). CONCLUSIONS: For patients undergoing mastectomy with implant-based reconstruction, the therapeutic mastectomy side has an increased risk of seroma formation.
引用
- Peoples AE, Waler AR, Duet ML, et al. Comparing Outcomes in the Therapeutic and Prophylactic Breast for Bilateral Mastectomy With Implant-Based Breast Reconstruction. Ann Plast Surg. 2023. PMID: 36811478. doi:10.1097/SAP.0000000000003460
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。